Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic.

Details for Australian Patent Application No. 2004290505 (hide)

Owner Novartis AG

Inventors Vasella, Daniel Lucius

Agent Davies Collison Cave

Pub. Number AU-B-2004290505

PCT Pub. Number WO2005/049013

Priority 0325605.4 03.11.03 GB

Filing date 2 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 20 September 2007

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/049013 Priority application(s): WO2005/049013

20 September 2007 Application Accepted

  Published as AU-B-2004290505

17 January 2008 Standard Patent Sealed

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290507-Radioactive radiation source for ophthalmic brachytherapy

2004290502-Combination of active substances with insecticidal properties